fundamental pharma.png
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
April 11, 2024 07:00 ET | Fundamental Pharma GmbH
PRESS RELEASE FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experienceDr. Beher...
msanders headshot
Carbonated Inc. names former Puny Human CEO as its new Chief Development Officer
April 03, 2024 11:43 ET | Carbonated Inc
Carbonated Inc. names former Puny Human CEO as its new Chief Development Officer following the closure of Puny Human in October 2023.
Solstice Gold Logo.jpg
Solstice Announces Appointment of New CFO
April 01, 2024 08:08 ET | Solstice Gold Corp.
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Solstice Gold Corp. (TSXV: SGC) (“Solstice”, “we”, “our” or the “Company”) is pleased to announce the appointment of Mark Laycock as...
logo_TRANSGENE.jpg
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer
March 27, 2024 12:45 ET | Transgene S.A.
Strasbourg, France, March 27, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to...
logo_TRANSGENE.jpg
Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources Humaines
March 27, 2024 12:45 ET | Transgene S.A.
Strasbourg, France – Le 27 mars 2024, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies contre le cancer reposant sur des vecteurs...
laverock_logo-640w.png
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
March 26, 2024 05:00 ET | Laverock Therapeutics
STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
CMRSurgical_Logo_RGB_Hi-res.jpg
CMR Surgical announces over 20,000 surgical cases completed using Versius
March 21, 2024 08:00 ET | CMR Surgical
Over 20,000 surgical cases completed using Versius The versatile surgical robot Versius has now been used to perform over 20,000 surgical cases across seven specialties with data collected in the...
CMRSurgical_Logo_RGB_Hi-res.jpg
CMR Surgical announces over 20,000 surgical cases completed using Versius
March 21, 2024 03:00 ET | CMR Surgical
Over 20,000 surgical cases completed using Versius The versatile surgical robot Versius has now been used to perform over 20,000 surgical cases across seven specialties with data collected in the...
fundamental pharma.png
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
March 20, 2024 02:00 ET | Fundamental Pharma GmbH
PRESS RELEASE FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director Appointment underscores FundaMental’s ambition to develop medicines for neurodegenerative...
astrivax_high resolution.png
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
March 19, 2024 02:00 ET | AstriVax
Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company’s business development, including...